0001209191-20-061669.txt : 20201203 0001209191-20-061669.hdr.sgml : 20201203 20201203192358 ACCESSION NUMBER: 0001209191-20-061669 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201201 FILED AS OF DATE: 20201203 DATE AS OF CHANGE: 20201203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chen Richard CENTRAL INDEX KEY: 0001779787 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38943 FILM NUMBER: 201368185 MAIL ADDRESS: STREET 1: C/O PERSONALIS, INC. STREET 2: 1330 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Personalis, Inc. CENTRAL INDEX KEY: 0001527753 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 275411038 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1330 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-752-1300 MAIL ADDRESS: STREET 1: 1330 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-01 0 0001527753 Personalis, Inc. PSNL 0001779787 Chen Richard C/O PERSONALIS, INC. 1330 O'BRIEN DRIVE MENLO PARK CA 94025 0 1 0 0 Chief Scientific Officer Common Stock 2020-12-01 4 M 0 40000 0.44 A 152750 D Common Stock 2020-12-01 4 S 0 14388 27.75 D 138362 D Common Stock 2020-12-01 4 S 0 25612 28.14 D 112750 D Common Stock 2020-12-02 4 S 0 293 27.76 D 112457 D Stock Option (Right to Buy) 0.44 2020-12-01 4 M 0 40000 0.00 D 2022-03-07 Common Stock 40000 31884 D Stock Option (Right to Buy) 28.17 2020-12-01 4 A 0 30000 0.00 A 2030-12-01 Common Stock 30000 30000 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The weighted average sale price for the transaction reported was $27.75, and the range of prices were between $27.02 and $28.01. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $28.14, and the range of prices were between $28.025 and $28.43. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Shares sold to cover tax obligation from settlement of vested restricted stock units. The shares subject to the option are fully vested and exercisable. The shares subject to the option vest in 12 equal monthly installments starting on April 16, 2023. /s/ Aaron Tachibana, Attorney-in-Fact 2020-12-03